Northwest Biotherapeutics (NWBO) Interest Coverage Ratio (2010 - 2026)

Northwest Biotherapeutics' Interest Coverage Ratio history runs 17 years deep, the most recent figure standing at 4.65 for Q1 2026.

• In Q1 2026, Interest Coverage Ratio rose 57.0% year-over-year to 4.65; the TTM figure through Mar 2026 stood at 5.82 (up 98.01% YoY), while the FY2025 annual figure was 6.89, down 2813.62% from the prior year.
• Interest Coverage Ratio for Q1 2026 stood at 4.65, up from 5.15 in the prior quarter.
• The five-year high for Interest Coverage Ratio was 3.84 in Q4 2023, with the low at 21.11 in Q4 2022.
• The 5-year median for Interest Coverage Ratio is 7.12 (2024), against an average of 7.15.
• Peak annual rise in Interest Coverage Ratio reached 118.18% in 2023, while the deepest fall reached 5868.15% in 2023.
• Northwest Biotherapeutics' Interest Coverage Ratio stood at 21.11 in 2022, then soared by 118.18% to 3.84 in 2023, then fell by 6.4% to 3.59 in 2024, then sank by 243.35% to 5.15 in 2025, then climbed by 9.79% to 4.65 in 2026.
• Business Quant data shows NWBO's Interest Coverage Ratio at 4.65 in Q1 2026, 5.15 in Q4 2025, and 5.46 in Q3 2025.